Filing Details

Accession Number:
0001140361-14-031976
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-12 18:54:14
Reporting Period:
2014-08-07
Filing Date:
2014-08-12
Accepted Time:
2014-08-12 18:54:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1567892 Mallinckrodt Plc MNK Pharmaceutical Preparations (2834) 981088325
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1035674 Paulson & Co Inc 1251 Avenue Of The Americas
New York NY 10020
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, $0.20 Par Value Acquisiton 2014-08-07 200,000 $69.69 7,199,800 No 4 P Indirect By Managed Funds and Accounts
Ordinary Shares, $0.20 Par Value Acquisiton 2014-08-07 500,200 $70.34 7,700,000 No 4 P Indirect By Managed Funds and Accounts
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Managed Funds and Accounts
No 4 P Indirect By Managed Funds and Accounts
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares, $0.20 Par Value Notional Principal Amount Derivative Agreement Acquisiton 2014-08-07 1 $0.00 16,500 $69.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1 2015-07-17 Yes 4 J Indirect
Footnotes
  1. Paulson & Co. Inc. ("Paulson") is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of Paulson Partners Enhanced LP, Paulson Enhanced Ltd, Paulson International Ltd, Paulson Partners LP and Paulson Partners Premium LP (collectively, the "Funds") and certain separately managed accounts (the "Separately Managed Accounts"). John Paulson is the controlling person of Paulson. All securities reported on this Form 4 are owned by the Funds or held in the Separately Managed Accounts.
  2. Each of Paulson and John Paulson may be deemed to indirectly beneficially own the securities directly owned by the Funds or held in the Separately Managed Accounts. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form.
  3. Notional principal amount derivative agreement (the "Derivative Agreement") in the form of a cash settled swap entered into by a Separately Managed Account representing a share equivalent of an aggregate of 16,500 Ordinary Shares. The Derivative Agreement provides the Separately Managed Account with economic results that are comparable to the economic results of ownership of Ordinary Shares payable on each settlement date applicable to the expiration or earlier termination of such Derivative Agreement, but does not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the Ordinary Shares that are the subject of the Derivative Agreement (such shares, the "Subject Shares"). Each of Paulson, the Funds, the Separately Managed Accounts and John Paulson disclaims beneficial ownership in the Subject Shares. The counterparty to the Derivative Agreement is an unaffiliated third party financial institution.